Crowley Wealth Management, Inc. Blueprint Medicines Corp Transaction History
Crowley Wealth Management, Inc.
- $113 Billion
- Q4 2024
A detailed history of Crowley Wealth Management, Inc. transactions in Blueprint Medicines Corp stock. As of the latest transaction made, Crowley Wealth Management, Inc. holds 200 shares of BPMC stock, worth $18,428. This represents 0.02% of its overall portfolio holdings.
Number of Shares
200Holding current value
$18,428% of portfolio
0.02%Shares
1 transactions
Others Institutions Holding BPMC
# of Institutions
380Shares Held
65.9MCall Options Held
1.6MPut Options Held
1.41M-
Vanguard Group Inc Valley Forge, PA6.77MShares$624 Million0.01% of portfolio
-
Black Rock Inc. New York, NY6.65MShares$612 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.68MShares$523 Million0.06% of portfolio
-
Wellington Management Group LLP Boston, MA4.28MShares$394 Million0.07% of portfolio
-
State Street Corp Boston, MA2.5MShares$230 Million0.01% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.5B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...